Is there a place for adjuvant therapy in IVF?

Area of Science:

• Reproductive Medicine
• In Vitro Fertilization
• Adjuvant Therapies

Background:

• Repeated failure to conceive with in vitro fertilization (IVF) presents a significant challenge in reproductive medicine.
• Adjuvant therapies are often employed empirically without a clear understanding of the underlying cause of conception failure.

Purpose of the Study:

• To review existing literature on adjuvant therapies for IVF.
• To determine the role and efficacy of adjuvant therapy in cases of repeated IVF failure.
• To educate healthcare professionals on interpreting studies and potential risks of adjuvant therapies.

Main Methods:

• Comprehensive literature search of multiple databases including PubMed, Medline, EMBASE, and Cochrane library.
• Inclusion of studies based on predefined criteria.
• Cross-referencing of published data to ensure thoroughness.

Main Results:

• Current adjuvant therapies for IVF are largely empirical, lacking specific diagnostic indications.
• Available randomized controlled trials (RCTs) show conflicting results regarding efficacy.
• No adjuvant therapy has demonstrated a definitive advantage in improving pregnancy or live birth rates.

Conclusions:

• The diagnosis of IVF failure is not specific enough to guide targeted adjuvant therapy selection.
• Certain unconfirmed therapies may be effective for specific patient subgroups, warranting further investigation.
• Endometrial biopsy shows promise but requires additional validation; chromosomal aberrations complicate maternal adjuvant therapy assessment.